Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges faced by conventional ADCs.
UT biochemistry major Milit Patel collaborated with researchers at Memorial Sloan Kettering Cancer Center on research published in a top cancer journal.
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.
1don MSN
AI-driven virtual screening uncovers two potent CDK9 inhibitors with anticancer effects in lab tests
A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback